Dr. Chava is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1514 Jefferson Hwy
Bh 634
New Orleans, LA 70121Phone+1 504-842-3260Fax+1 504-842-3193
Summary
- Dr. Pavan Chava is an endocrinologist in New Orleans, LA and is affiliated with Ochsner Medical Center. He received his medical degree from Nova Southeastern University - College of Osteopathic Medicine and has been in practice 13 years. He specializes in diabetes, lipid metabolism, and thyroid and is experienced in hypoglycemia. He has 4 publications and over 50 citings.
Education & Training
Ochsner Clinic FoundationFellowship, Endocrinology, Diabetes, and Metabolism, 2007 - 2009- Ochsner Clinic FoundationResidency, Internal Medicine, 2004 - 2007
Nova Southeastern University College of Osteopathic MedicineClass of 2004
Certifications & Licensure
LA State License 2006 - 2025
MS State License 2020 - 2025
AL State License 2021 - 2024
FL State License 2020 - 2022- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 18 citationsRationale for a titratable fixed-ratio co-formulation of a basal insulin analog and a glucagon-like peptide 1 receptor agonist in patients with type 2 diabetes.Lawrence Blonde, John E. Anderson, Pavan Chava, Jared A. Dendy
Current Medical Research and Opinion. 2019-05-01 - 13 citationsPredictors of outcomes in patients with type 2 diabetes in the lixisenatide GetGoal clinical trials.Lawrence Blonde, Pavan Chava, Terry Dex, Jay Lin, Elena Nikonova
Diabetes, Obesity & Metabolism. 2017-02-01 - 17 citationsAchievement of Target A1C <7.0% (<53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical PracticeLawrence Blonde, Stephen A. Brunton, Pavan Chava, Rong Zhou, Juliana Meyers
Diabetes Spectrum. 2019-05-01
Press Mentions
At Ochsner, Innovation Happens Inside and Outside System’s WallsDecember 30th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
